Gimnez-Palomo A, Dodd S, Anmella G, et al
adults, driven by increasing obesity rates and growing awareness of weight management options
it's a guardian of cellular health
A large 2023 study including people without diabetes who were using GLP-1 agonists for weight loss found that this class of medications may increase the risk of gastrointestinal conditions, such as gastroparesis
And if youre on medications or have health conditions, a chat with your doctor is non-negotiable
However, when we chelated extracellular Ca 2+ with EGTA, exendin-4 still suppressed the GABA currents in GCs, suggesting that Ca 2+ entry through voltage-gated channels was not be involved in the action of exendin-4 under our experimental conditions